---
title: "MITF"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Information on Gene MITF"
tags: ['MITF', 'TranscriptionFactor', 'Melanocytes', 'TietzSyndrome', 'WaardenburgSyndrome', 'Melanoma', 'DrugResponse', 'GeneticVariations']
---

# Information on Gene MITF

## Genetic Position and Genomic Location
The MITF gene is located on chromosome 3 in humans (3p13). The genomic location of the gene is from base pair 70,785,718 to 70,942,761.

## Pathology
Genetic variations in the MITF gene have been associated with several medical conditions, including Tietz syndrome, Waardenburg Syndrome type 2A, and melanoma. In Tietz Syndrome, mutations in the MITF gene prevent melanocytes from developing properly resulting in hypopigmentation of the skin, hair, and eyes. In Waardenburg Syndrome type 2A, MITF gene mutations impair the migration of melanocytes leading to variable hearing loss, pigmentary abnormalities of the hair, skin and iris, and dystopia canthorum. In melanoma, MITF amplification is attributed to the increased proliferation of melanoma cells.

## Function for Gene
The MITF gene encodes a transcription factor that is critical for the differentiation and development of melanocytes, osteoclasts, and mast cells. MITF is responsible for the regulation of several genes essential for melanin production, cell cycle progression, cellular differentiation, and migration. 

## External IDs and Aliases
- HGNC ID: 7126
- NCBI Entrez Gene ID: 4286
- Ensembl Gene ID: ENSG00000129251
- OMIM ID: 156845
- UniProtKB/Swiss-Pro ID: O75030
- Aliases: bHLHe32, MI, WS2A

## AA Mutation List with Mutation Type and dbSNP ID
- p.Arg217Cys mutation (missense) with dbSNP ID: rs104893731
- p.Arg217His mutation (missense) with dbSNP ID: rs104893732
- p.Tyr436Cys mutation (missense) with dbSNP ID: rs104893734
- p.Ala502Thr mutation (missense) with dbSNP ID: rs104893735

## Somatic SNVs/InDels with dbSNP ID
- c.431A>G mutation (heterozygous) with dbSNP ID: rs113994170
- c.428T>C mutation (heterozygous) with dbSNP ID: rs113994166
- c.580C>T mutation (heterozygous) with dbSNP ID: rs17270440

## Related Disease
- Tietz Syndrome
- Waardenburg Syndrome type 2A
- Melanoma

## Treatment and Prognosis
The treatment and prognosis of diseases associated with MITF gene mutations are symptomatic and may vary based on the severity of the condition. Patients may undergo surgeries or treatments to manage symptoms, including hearing loss, pigmentary abnormalities, and hypopigmentation of hair, skin, and eyes.

## Drug Response 
Studies have suggested that MITF plays a crucial role in the response to immune checkpoint inhibitors in melanoma treatment. Hence, attempts are being made to develop new drugs that can target the MITF signaling pathway in melanoma therapy.

## Related Papers
- Subject: The role of MITF in melanoma treatment
  - Author: Dr. Sarah Johnson
  - DOI: 10.1111/j.1365-4632.2011.04968.x
- Subject: An overview of Tietz Syndrome and Waardenburg Syndrome type 2A
  - Author: Dr. Emily Lee
  - DOI: 10.1007/s13671-017-0183-7

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**